Three pillars on one HSC engineering foundation.
Banked donor products for diseases that need cells now, an autologous path for diseases that need tolerance, and a manufacturing concept that could bring both to the bedside.
Banked engineered donor HSPCs
Healthy-donor cells engineered to stay invisible to recipient immunity for as long as each disease requires — banked, cryopreserved, and infused without HLA matching or donor-search delay.
Autologous HSC engineering
A patient's own HSCs engineered to teach their immune system what to tolerate — donor-specific tolerance in transplantation, and regulation directed only at inflamed tissue in autoimmune disease.
Closed-loop extracorporeal platform
A closed, automated engineering concept designed to bring controlled cell engineering to the point of care — reducing manufacturing complexity and supporting scalable workflows.
See how the three pillars sequence.
The pipeline page sets out stage, near-term milestones and the market model for each.